APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flu Shots

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Flu Shots Market Outlook and Growth Opportunities 2026

19 December 2025199 pages

Choose your research edition.

Industry ResearchFlu Shots Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Flu Shots Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Flu Shots Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flu Shots Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Flu Shots Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Flu Shots market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Flu Shots is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Flu Shots is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Flu Shots is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Flu Shots market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Flu Shots market include SANOFI, GSK, VAXTEC, TIANYUAN BIO-PHARMA, SIOBP, SINOVAC, LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT, HUALAN BIO and CHANGSHENG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Flu Shots market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Flu Shots and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Flu Shots sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Flu Shots market size, projected growth trends, production technologies, key applications, and end-use industries.

Flu Shots Segment by Company

SANOFI

GSK

VAXTEC

TIANYUAN BIO-PHARMA

SIOBP

SINOVAC

LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT

HUALAN BIO

CHANGSHENG

CCBIO

ALEPH BIOMEDICAL

Flu Shots Segment by Type

Influenza Whole Virus Vaccines

Influenza Virus Subunit Vaccines

Influenza Virus Split Vaccines

Flu Shots Segment by Application

Avian Influenza Virus-A

Avian Influenza Virus-B

Flu Shots Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Flu Shots status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Flu Shots market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Flu Shots significant trends, drivers, influence factors in global and regions.

6. To analyze Flu Shots competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Shots market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flu Shots and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Shots.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Flu Shots market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Flu Shots industry.

Chapter 3: Detailed analysis of Flu Shots manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Flu Shots in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Flu Shots in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Flu Shots Industry Trends Table 2. Flu Shots Industry Drivers Table 3. Flu Shots Industry Opportunities and Challenges Table 4. Flu Shots Industry Restraints Table 5. Global Flu Shots Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Flu Shots Revenue Share by Company (2021-2026) Table 7. Global Flu Shots Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Flu Shots Sales Volume Share by Company (2021-2026) Table 9. Global Flu Shots Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Flu Shots Company Ranking, (2024-2026) & (USD Million) Table 11. Global Flu Shots Key Company Manufacturing Base & Headquarters Table 12. Global Flu Shots Company, Product Type & Application Table 13. Global Flu Shots Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Flu Shots by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Influenza Whole Virus Vaccines Table 18. Significant Companies of Influenza Virus Subunit Vaccines Table 19. Significant Companies of Influenza Virus Split Vaccines Table 20. Global Flu Shots Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Flu Shots Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Flu Shots Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Flu Shots Sales Volume Share by Type (2021-2026) Table 24. Global Flu Shots Sales Volume Share by Type (2027-2032) Table 25. Global Flu Shots Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Flu Shots Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Flu Shots Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Flu Shots Sales Value Share by Type (2021-2026) Table 29. Global Flu Shots Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Avian Influenza Virus-A Table 31. Significant Companies of Avian Influenza Virus-B Table 32. Global Flu Shots Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Flu Shots Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Flu Shots Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Flu Shots Sales Volume Share by Application (2021-2026) Table 36. Global Flu Shots Sales Volume Share by Application (2027-2032) Table 37. Global Flu Shots Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Flu Shots Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Flu Shots Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Flu Shots Sales Value Share by Application (2021-2026) Table 41. Global Flu Shots Sales Value Share by Application (2027-2032) Table 42. Global Flu Shots Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Flu Shots Sales by Region (2021-2026) & (K Units) Table 44. Global Flu Shots Sales Market Share by Region (2021-2026) Table 45. Global Flu Shots Sales by Region (2027-2032) & (K Units) Table 46. Global Flu Shots Sales Market Share by Region (2027-2032) Table 47. Global Flu Shots Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Flu Shots Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Flu Shots Sales Value Share by Region (2021-2026) Table 50. Global Flu Shots Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Flu Shots Sales Value Share by Region (2027-2032) Table 52. Global Flu Shots Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Flu Shots Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Flu Shots Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Flu Shots Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Flu Shots Sales by Country (2021-2026) & (K Units) Table 57. Global Flu Shots Sales Market Share by Country (2021-2026) Table 58. Global Flu Shots Sales by Country (2027-2032) & (K Units) Table 59. Global Flu Shots Sales Market Share by Country (2027-2032) Table 60. Global Flu Shots Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Flu Shots Sales Value Market Share by Country (2021-2026) Table 62. Global Flu Shots Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Flu Shots Sales Value Market Share by Country (2027-2032) Table 64. SANOFI Company Information Table 65. SANOFI Business Overview Table 66. SANOFI Flu Shots Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. SANOFI Flu Shots Product Portfolio Table 68. SANOFI Recent Development Table 69. GSK Company Information Table 70. GSK Business Overview Table 71. GSK Flu Shots Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. GSK Flu Shots Product Portfolio Table 73. GSK Recent Development Table 74. VAXTEC Company Information Table 75. VAXTEC Business Overview Table 76. VAXTEC Flu Shots Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. VAXTEC Flu Shots Product Portfolio Table 78. VAXTEC Recent Development Table 79. TIANYUAN BIO-PHARMA Company Information Table 80. TIANYUAN BIO-PHARMA Business Overview Table 81. TIANYUAN BIO-PHARMA Flu Shots Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. TIANYUAN BIO-PHARMA Flu Shots Product Portfolio Table 83. TIANYUAN BIO-PHARMA Recent Development Table 84. SIOBP Company Information Table 85. SIOBP Business Overview Table 86. SIOBP Flu Shots Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. SIOBP Flu Shots Product Portfolio Table 88. SIOBP Recent Development Table 89. SINOVAC Company Information Table 90. SINOVAC Business Overview Table 91. SINOVAC Flu Shots Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. SINOVAC Flu Shots Product Portfolio Table 93. SINOVAC Recent Development Table 94. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Company Information Table 95. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Business Overview Table 96. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolio Table 98. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Development Table 99. HUALAN BIO Company Information Table 100. HUALAN BIO Business Overview Table 101. HUALAN BIO Flu Shots Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. HUALAN BIO Flu Shots Product Portfolio Table 103. HUALAN BIO Recent Development Table 104. CHANGSHENG Company Information Table 105. CHANGSHENG Business Overview Table 106. CHANGSHENG Flu Shots Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. CHANGSHENG Flu Shots Product Portfolio Table 108. CHANGSHENG Recent Development Table 109. CCBIO Company Information Table 110. CCBIO Business Overview Table 111. CCBIO Flu Shots Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. CCBIO Flu Shots Product Portfolio Table 113. CCBIO Recent Development Table 114. ALEPH BIOMEDICAL Company Information Table 115. ALEPH BIOMEDICAL Business Overview Table 116. ALEPH BIOMEDICAL Flu Shots Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. ALEPH BIOMEDICAL Flu Shots Product Portfolio Table 118. ALEPH BIOMEDICAL Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Flu Shots Distributors List Table 122. Flu Shots Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Flu Shots Product Image Figure 2. Global Flu Shots Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flu Shots Sales Value (2021-2032) & (US$ Million) Figure 4. Global Flu Shots Sales (2021-2032) & (K Units) Figure 5. Global Flu Shots Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Flu Shots Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Influenza Whole Virus Vaccines Image Figure 10. Influenza Virus Subunit Vaccines Image Figure 11. Influenza Virus Split Vaccines Image Figure 12. Global Flu Shots Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Flu Shots Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Flu Shots Sales Volume Share by Type (2021-2032) Figure 15. Global Flu Shots Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Flu Shots Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Flu Shots Sales Value Share by Type (2021-2032) Figure 18. Avian Influenza Virus-A Image Figure 19. Avian Influenza Virus-B Image Figure 20. Global Flu Shots Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Flu Shots Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Flu Shots Sales Volume Share by Application (2021-2032) Figure 23. Global Flu Shots Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Flu Shots Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Flu Shots Sales Value Share by Application (2021-2032) Figure 26. Global Flu Shots Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Flu Shots Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Flu Shots Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Flu Shots Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Flu Shots Sales Value (2021-2032) & (US$ Million) Figure 31. North America Flu Shots Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Flu Shots Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Flu Shots Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Flu Shots Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Flu Shots Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Flu Shots Sales Value (2021-2032) & (US$ Million) Figure 37. South America Flu Shots Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Flu Shots Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Flu Shots Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Flu Shots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Flu Shots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Flu Shots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Flu Shots Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Flu Shots Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Influenza Whole Virus Vaccines
  • Influenza Virus Subunit Vaccines
  • Influenza Virus Split Vaccines
Applications
  • Avian Influenza Virus-A
  • Avian Influenza Virus-B
Companies covered
  • SANOFI
  • GSK
  • VAXTEC
  • TIANYUAN BIO-PHARMA
  • SIOBP
  • SINOVAC
  • LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
  • HUALAN BIO
  • CHANGSHENG
  • CCBIO
  • ALEPH BIOMEDICAL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Flu Shots Sales Value (2021-2032)
  4. 1.2.2 Global Flu Shots Sales Volume (2021-2032)
  5. 1.2.3 Global Flu Shots Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Flu Shots Market Dynamics
  1. 2.1 Flu Shots Industry Trends
  2. 2.2 Flu Shots Industry Drivers
  3. 2.3 Flu Shots Industry Opportunities and Challenges
  4. 2.4 Flu Shots Industry Restraints
3 Flu Shots Market by Company
  1. 3.1 Global Flu Shots Company Revenue Ranking in 2025
  2. 3.2 Global Flu Shots Revenue by Company (2021-2026)
  3. 3.3 Global Flu Shots Sales Volume by Company (2021-2026)
  4. 3.4 Global Flu Shots Average Price by Company (2021-2026)
  5. 3.5 Global Flu Shots Company Ranking (2024-2026)
  6. 3.6 Global Flu Shots Company Manufacturing Base and Headquarters
  7. 3.7 Global Flu Shots Company Product Type and Application
  8. 3.8 Global Flu Shots Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Flu Shots Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Flu Shots Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Flu Shots Market by Type
  1. 4.1 Flu Shots Type Introduction
  2. 4.1.1 Influenza Whole Virus Vaccines
  3. 4.1.2 Influenza Virus Subunit Vaccines
  4. 4.1.3 Influenza Virus Split Vaccines
  5. 4.2 Global Flu Shots Sales Volume by Type
  6. 4.2.1 Global Flu Shots Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Flu Shots Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Flu Shots Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Flu Shots Sales Value by Type
  10. 4.3.1 Global Flu Shots Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Flu Shots Sales Value by Type (2021-2032)
  12. 4.3.3 Global Flu Shots Sales Value Share by Type (2021-2032)
5 Flu Shots Market by Application
  1. 5.1 Flu Shots Application Introduction
  2. 5.1.1 Avian Influenza Virus-A
  3. 5.1.2 Avian Influenza Virus-B
  4. 5.2 Global Flu Shots Sales Volume by Application
  5. 5.2.1 Global Flu Shots Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Flu Shots Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Flu Shots Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Flu Shots Sales Value by Application
  9. 5.3.1 Global Flu Shots Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Flu Shots Sales Value by Application (2021-2032)
  11. 5.3.3 Global Flu Shots Sales Value Share by Application (2021-2032)
6 Flu Shots Regional Sales and Value Analysis
  1. 6.1 Global Flu Shots Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Flu Shots Sales by Region (2021-2032)
  3. 6.2.1 Global Flu Shots Sales by Region: 2021-2026
  4. 6.2.2 Global Flu Shots Sales by Region (2027-2032)
  5. 6.3 Global Flu Shots Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Flu Shots Sales Value by Region (2021-2032)
  7. 6.4.1 Global Flu Shots Sales Value by Region: 2021-2026
  8. 6.4.2 Global Flu Shots Sales Value by Region (2027-2032)
  9. 6.5 Global Flu Shots Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Flu Shots Sales Value (2021-2032)
  12. 6.6.2 North America Flu Shots Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Flu Shots Sales Value (2021-2032)
  15. 6.7.2 Europe Flu Shots Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Flu Shots Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Flu Shots Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Flu Shots Sales Value (2021-2032)
  21. 6.9.2 South America Flu Shots Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Flu Shots Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Flu Shots Sales Value Share by Country, 2025 VS 2032
7 Flu Shots Country-level Sales and Value Analysis
  1. 7.1 Global Flu Shots Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Flu Shots Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Flu Shots Sales by Country (2021-2032)
  4. 7.3.1 Global Flu Shots Sales by Country (2021-2026)
  5. 7.3.2 Global Flu Shots Sales by Country (2027-2032)
  6. 7.4 Global Flu Shots Sales Value by Country (2021-2032)
  7. 7.4.1 Global Flu Shots Sales Value by Country (2021-2026)
  8. 7.4.2 Global Flu Shots Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Flu Shots Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Flu Shots Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Flu Shots Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Flu Shots Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Flu Shots Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Flu Shots Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Flu Shots Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Flu Shots Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Flu Shots Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Flu Shots Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Flu Shots Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Flu Shots Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Flu Shots Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Flu Shots Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Flu Shots Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Flu Shots Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Flu Shots Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Flu Shots Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Flu Shots Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Flu Shots Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Flu Shots Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Flu Shots Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Flu Shots Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Flu Shots Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Flu Shots Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Flu Shots Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Flu Shots Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Flu Shots Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Flu Shots Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Flu Shots Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Flu Shots Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Flu Shots Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Flu Shots Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Flu Shots Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Flu Shots Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Flu Shots Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Flu Shots Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Flu Shots Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Flu Shots Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Flu Shots Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Flu Shots Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Flu Shots Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Flu Shots Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Flu Shots Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Flu Shots Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Flu Shots Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Flu Shots Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Flu Shots Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Flu Shots Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Flu Shots Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Flu Shots Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Flu Shots Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Flu Shots Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Flu Shots Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Flu Shots Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Flu Shots Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Flu Shots Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Flu Shots Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Flu Shots Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Flu Shots Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Flu Shots Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Flu Shots Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Flu Shots Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Flu Shots Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Flu Shots Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Flu Shots Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Flu Shots Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Flu Shots Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Flu Shots Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Flu Shots Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Flu Shots Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Flu Shots Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Flu Shots Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Flu Shots Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Flu Shots Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Flu Shots Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Flu Shots Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Flu Shots Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Flu Shots Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Flu Shots Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Flu Shots Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Flu Shots Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Flu Shots Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Flu Shots Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 SANOFI
  2. 8.1.1 SANOFI Company Information
  3. 8.1.2 SANOFI Business Overview
  4. 8.1.3 SANOFI Flu Shots Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 SANOFI Flu Shots Product Portfolio
  6. 8.1.5 SANOFI Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Flu Shots Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GSK Flu Shots Product Portfolio
  12. 8.2.5 GSK Recent Developments
  13. 8.3 VAXTEC
  14. 8.3.1 VAXTEC Company Information
  15. 8.3.2 VAXTEC Business Overview
  16. 8.3.3 VAXTEC Flu Shots Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 VAXTEC Flu Shots Product Portfolio
  18. 8.3.5 VAXTEC Recent Developments
  19. 8.4 TIANYUAN BIO-PHARMA
  20. 8.4.1 TIANYUAN BIO-PHARMA Company Information
  21. 8.4.2 TIANYUAN BIO-PHARMA Business Overview
  22. 8.4.3 TIANYUAN BIO-PHARMA Flu Shots Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 TIANYUAN BIO-PHARMA Flu Shots Product Portfolio
  24. 8.4.5 TIANYUAN BIO-PHARMA Recent Developments
  25. 8.5 SIOBP
  26. 8.5.1 SIOBP Company Information
  27. 8.5.2 SIOBP Business Overview
  28. 8.5.3 SIOBP Flu Shots Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 SIOBP Flu Shots Product Portfolio
  30. 8.5.5 SIOBP Recent Developments
  31. 8.6 SINOVAC
  32. 8.6.1 SINOVAC Company Information
  33. 8.6.2 SINOVAC Business Overview
  34. 8.6.3 SINOVAC Flu Shots Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 SINOVAC Flu Shots Product Portfolio
  36. 8.6.5 SINOVAC Recent Developments
  37. 8.7 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
  38. 8.7.1 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Company Information
  39. 8.7.2 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Business Overview
  40. 8.7.3 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Flu Shots Product Portfolio
  42. 8.7.5 LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT Recent Developments
  43. 8.8 HUALAN BIO
  44. 8.8.1 HUALAN BIO Company Information
  45. 8.8.2 HUALAN BIO Business Overview
  46. 8.8.3 HUALAN BIO Flu Shots Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 HUALAN BIO Flu Shots Product Portfolio
  48. 8.8.5 HUALAN BIO Recent Developments
  49. 8.9 CHANGSHENG
  50. 8.9.1 CHANGSHENG Company Information
  51. 8.9.2 CHANGSHENG Business Overview
  52. 8.9.3 CHANGSHENG Flu Shots Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 CHANGSHENG Flu Shots Product Portfolio
  54. 8.9.5 CHANGSHENG Recent Developments
  55. 8.10 CCBIO
  56. 8.10.1 CCBIO Company Information
  57. 8.10.2 CCBIO Business Overview
  58. 8.10.3 CCBIO Flu Shots Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 CCBIO Flu Shots Product Portfolio
  60. 8.10.5 CCBIO Recent Developments
  61. 8.11 ALEPH BIOMEDICAL
  62. 8.11.1 ALEPH BIOMEDICAL Company Information
  63. 8.11.2 ALEPH BIOMEDICAL Business Overview
  64. 8.11.3 ALEPH BIOMEDICAL Flu Shots Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ALEPH BIOMEDICAL Flu Shots Product Portfolio
  66. 8.11.5 ALEPH BIOMEDICAL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Flu Shots Value Chain Analysis
  2. 9.1.1 Flu Shots Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Flu Shots Sales Mode & Process
  6. 9.2 Flu Shots Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Flu Shots Distributors
  9. 9.2.3 Flu Shots Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst